Separate names with a comma.
Colleagues, In May 2006, the good folks at Cafepharma took a chance on letting a physician who had stumbled onto the Darkened Sample Closet and...
Unless I am missing something in your question, I'm going to have to defer to the industry people here. From the physician end, any dollar amount...
I don't mean to sound flippant, but if there is money to be made (as there is in tinnitus), research in the area is a certainty; but I'm not aware...
Thanks for your post, and I’m glad you’ve found some helpful info here. You obviously know your territory better than I do, but I wonder if part...
Thanks for your post and your questions. With the disclaimer that all physicians are different (with the possible exception of being hard to...
Thanks for your post. Interesting anecdote that speaks to the medical culture that is hopefully improving. I've always been fascinated that, at...
I thought others here might chime in first - my perception is that this is information the company itself would provide you. Perhaps I'm...
This is a fair point. However, price (usually directly proportional to PA requirements) matters as well. It sounds like your perceptions are...
This story came across the CP feed recently. What are your thoughts/experiences in this regard?...
I have not yet used these meds, although there may be a couple of patients with very high LDL, CVD and statin intolerance in whom I would consider...
I might be able to give you a better answer if I knew your product, but in general terms- You are technically correct, but the term "prior...
Just to make sure I'm on the same page with you - the materials you are describing sound a little more broad than the literature I'm accustomed to...
It really depends on the physician. I tend to prefer scientific information, though some physicians are more focused on (if I'm understanding...
Not yet (IE, there might be some that I haven't identified), and I haven't had an Amgen rep call on me for a year or more.
Not anything new clinically - anything else that has evolved (besides approval news) that you think is pertinent for discussion? Thanks for...
Well put!
Do you think a regulatory requirement to disclose all raw data would adequately address this concern? Thanks, all, for your comments!
Very interesting, thanks for the links. If I'm doing the math correctly, the NNT to prevent 1 event over 1 year is 85. Impressive for the...
Certainly statin intolerance is a common occurrence, but I'm not yet familiar with the risk reduction data for those agents. Do you have some...
A very interesting article. Thank you for sharing. Perhaps we ultimately agree on this-yes, the American Medical Association should be doing more...
